Comparison of genotypic resistance mutations in treatment-naive HIV type 1-infected patients in Korea and China

AIDS Research and Human Retroviruses

Volumn 26, Issue 2, 2010, Pages 217-221

  Chin, Bum Sik ^a   Choi, Jun Yong ^a   Han, Yang ^b   Kuang, Jiqiu ^b   Li, Yanling ^b   Han, Sang Hoon ^a   Choi, Heekyoung ^a   Chae, Yun Tae ^a   Jin, Sung Joon ^a   Baek, Ji Hyeon ^a   Lim, Young Soun ^a   Kim, Chang Oh ^a   Song, Young Goo ^a   Yong, Dongeun ^a   Li, Taisheng ^b   Kim, June Myung ^a  

^a Yonsei University College of Medicine   (South Korea)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIVIRAL RESISTANCE; ARTICLE; CHINA; CONTROLLED STUDY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KOREA; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; VIRUS MUTATION;

ADULT; CHINA; CLUSTER ANALYSIS; DRUG RESISTANCE, VIRAL; FEMALE; GEOGRAPHY; HIV INFECTIONS; HIV-1; HUMANS; KOREA; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHYLOGENY; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS; YOUNG ADULT;

EID: 77149132521     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0157     Document Type: Article

References (13)

1. Zhang X, Li S, Li X, et al.: Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China. AIDS 2007;21(Suppl 8):S59-65.
2. Chang S-Y, Chen M-Y, Lee C-N, et al.: Trends of anti-retroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan. J Antimicrobial Chemother 2008;61(3):689-693.
3. Choi JY, Kim EJ, Park YK, Lee JS, and Kim SS: National survey for drug-resistant variants in newly diagnosed anti-retroviral drug-naive patients with HIV/AIDS in South Korea: 1999-2005. J Acquir Immune Defic Syndr 2008;49(3): 237-242.
4. Ibe S, Hattori J, Fujisaki S, et al.: Trend of drug-resistant HIV type 1 emergence among therapy-naive patients in Nagoya, Japan: An 8-year surveillance from 1999 to 2006. AIDS Res Hum Retroviruses 2008;24(1):7-14.
5. Lan YC, Elbeik T, Dileanis J, et al.: Molecular epidemiology of HIV-1 subtypes and drug resistant strains in Taiwan. J Med Virol 2008;80(2):183-191.
6. Shafer RW, Rhee SY, Pillay D, et al.: HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS 2007;21(2):215-223.
7. Turner D, Brenner B, Moisi D, et al.: Nucleotide and amino acid polymorphisms at drug resistance sites in non-B-subtype variants of human immunodeficiency virus type 1. Antimicrob Agents Chemother 2004;48(8):2993-2998.
8. Kuritzkes DR, Lalama CM, Ribaudo HJ, et al.: Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1 infected subjects. J Infect Dis 2008; 197(6):867-870.
9. Zhang F, Haberer JE, Wang Y, et al.: The Chinese free antiretroviral treatment program: Challenges and responses. AIDS 2007;21(Suppl 8):S143-148.
10. Kim MS, Shin SY, Park YS, et al.: Therapeutic response of HAART and analysis of related factors in Korean HIV-infected persons. Infect Chemother 2007;39(3):142-150.
11. Mills EJ, Nachega JB, Buchan I, et al.: Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA 2006;296(6):679-690.
12. Kang MR, Cho YK, Chun J, et al.: Phylogenetic analysis of the nef gene reveals a distinctive monophyletic clade in Korean HIV-1 cases. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17(1):58-68.
13. Han X, Zhang M, Dai D, et al.: Genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV/AIDS patients living in Liaoning Province, China: Baseline prevalence and subtype-specific difference. AIDS Res Hum Retroviruses 2007;23(3):357-364.